Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Seminars in Arthritis and Rheumatism|March 9, 2025
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseasesKeith M Sullivan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?Jason W Chien, Keith M Sullivan
Current Opinion in Hematology|September 7, 2019
Application of stem cell transplantation in autoimmune diseasesSue-Ann Ng, Keith M Sullivan
Blood Reviews|January 24, 2006
Chronic graft-versus-host diseaseMitchell E Horwitz, Keith M Sullivan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United StatesKeith M Sullivan, Paolo Muraro, Alan Tyndall
Rheumatology (Oxford, England)|November 10, 2022
Improving outcomes in scleroderma: recent progress of cell-based therapiesDinesh Khanna, Nancy Krieger, Keith M Sullivan
Hematology. American Society of Hematology. Education Program|November 10, 2001
Bone Marrow Transplantation for Non-Malignant DiseaseKeith M. Sullivan, Robertson Parkman, Mark C. Walters
Blood|January 25, 2019
How I treat refractory chronic graft-versus-host diseaseStefanie Sarantopoulos, Adela R Cardones, Keith M Sullivan
Journal of Scleroderma and Related Disorders|April 7, 2022
Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literatureAnkoor Shah, J Spierings, J M van Laar, et al.
Transplantation and Cellular Therapy|October 21, 2022
Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy TrialsLakshmanan Krishnamurti, Donna Neuberg, Keith M Sullivan, et al.
Pageof 7